All Articles

Ottawa approves a key road to the Ring of Fire, balancing Indigenous-led growth against deep environmental and inter-community rifts. What does this signal?

Aecon is consolidating its power, buying out Oaktree's stake in its booming utilities arm. This move positions it to dominate the market for grid modernization.

On July 23, PG&E faces investors, but 16 million Californians will be listening. The Q2 call is a crucial test of its financial health and safety promises.

Orion S.A.'s minor dividend hike projects stability, but a look at recent financials and market trends reveals a more complex picture for the carbon black giant.

As investors bet on AI creating 'God,' one expert warns of a bubble. With key earnings reports looming, are today's massive valuations built on faith or fundamentals?

A new breed of private club is emerging in Dubai, promising to turn high-earning founders into lasting dynasties. But what's really behind the velvet rope?

Reformation's IPO filing reveals a story of rapid growth, shrinking profits, and pre-IPO debt. Can the sustainable fashion darling keep its soul on Wall Street?

Passing a stress test is expected. For Amex, maintaining the minimum capital buffer signals deep confidence in its premium model and a green light for shareholder returns.

With its 12th straight annual dividend increase, The First Bancorp shines. But does this reflect the strength of community banking or mask regional risks?

The NYSE delisted Lanvin Group's warrants, citing an 'abnormally low price.' This move highlights the exchange's tougher stance and raises questions about the luxury firm.

As The Baldwin Group preps its Q2 results, all eyes are on its strategy. Will the call reveal a path to resilience or a prelude to a private equity sale?

Beyond charity, a $7.2M Central Florida project reveals a replicable model where public, private, and non-profit sectors unite to build economic stability.

As rising property values outpace federal coverage, Neptune Flood's new $15M limit signals a pivotal shift in how America protects its most valuable assets.

uniQure's upsized $259M offering signals massive investor confidence, fueling its Huntington's therapy, AMT-130, and reshaping the gene therapy landscape.

A century-old, employee-owned company invests nearly $800 million to secure jobs and slash emissions, revealing a blueprint for American industrial renewal.

As Ottawa rolls out tough new bail laws to combat retail theft, Halifax businesses wonder if it's enough to tackle a crisis fueled by addiction and resource gaps.

A Pennsylvania firm's new 3D-printed titanium cervical cage has been used in a patient for the first time, heralding a new era of spinal implants.

New data on a once-weekly drug and a novel combination therapy signal a major shift in treating achondroplasia, moving the focus from height to quality of life.

With court approval secured, First Capital's $9.4B sale to KingSett and Choice Properties is nearly complete, signaling a major consolidation in Canada's prized grocery-anchored real estate market.

As McGrath sets its Q2 earnings date, investors watch to see if its tech rental boom can offset modular market headwinds and protect a 35-year dividend streak.